Caxton Associates (New York)’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Caxton Associates (New York)'s AMGN Position: Q4 2024 in Review
Caxton Associates (New York) reduced its Amgen (AMGN) stake by 67% in Q4 2024, selling an estimated $1.13M and leaving 1,854 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #338.
Caxton Associates (New York) first reported a position in AMGN in Q1 2017 and has held it in 14 quarters since. The position peaked at $3.82M in Q4 2023. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Caxton Associates (New York) held 1,854 shares of Amgen worth $483K as of Q4 2024.
- Caxton Associates (New York) sold 3,820 Amgen shares in Q4 2024, an estimated $1.13M.
- Amgen made up 0.02% of Caxton Associates (New York)'s portfolio in Q4 2024, its #338 holding.
- Caxton Associates (New York) first reported a position in Amgen in Q1 2017 and has held it in 14 quarters since.
- Caxton Associates (New York)'s Amgen position peaked at $3.82M in Q4 2023.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.